Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (981-990 of 1,873) with videos related to

Pageof 188
Sort By:
Journal of the American College of Cardiology|May 13, 2024
Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal FunctionShingo Matsumoto, Alasdair D Henderson, Li Shen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 18, 2020
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysisMatthew M Y Lee, Kieran F Docherty, Naveed Sattar, et al.
Journal of the American Heart Association|July 21, 2022
Association of Pulmonary Function With Late-Life Cardiac Function and Heart Failure Risk: The ARIC StudySergio H R Ramalho, Brian L Claggett, George R Washko, et al.
Journal of the American College of Cardiology|July 16, 2016
Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure HospitalizationAkshay S Desai, Brian L Claggett, Milton Packer, et al.
The Lancet. Diabetes & Endocrinology|January 18, 2016
Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trialHiddo J L Heerspink, Frederik Persson, Barry M Brenner, et al.
Nature Communications|January 20, 2016
New observations on maternal age effect on germline de novo mutationsWendy S W Wong, Benjamin D Solomon, Dale L Bodian, et al.
Journal of the American Heart Association|November 23, 2014
Electrocardiographic deep terminal negativity of the P wave in V(1) and risk of sudden cardiac death: the Atherosclerosis Risk in Communities (ARIC) studyLarisa G Tereshchenko, Charles A Henrikson, Nona Sotoodehnia, et al.
Hypertension (Dallas, Tex. : 1979)|May 18, 2022
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities StudyJenifer M Brown, Magnus O Wijkman, Brian L Claggett, et al.
Journal of Cardiac Failure|May 31, 2022
Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCATEbrahim Barkoudah, Brian L Claggett, Eldrin F Lewis, et al.
Circulation|January 7, 2021
Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical TrialsRavi B Patel, Jozine M Ter Maaten, João Pedro Ferreira, et al.
Pageof 188

Showing results (981-990 of 1,873) with videos related to

Sort By:
Pageof 188
Journal of the American College of Cardiology|May 13, 2024
Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal FunctionShingo Matsumoto, Alasdair D Henderson, Li Shen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 18, 2020
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysisMatthew M Y Lee, Kieran F Docherty, Naveed Sattar, et al.
Journal of the American Heart Association|July 21, 2022
Association of Pulmonary Function With Late-Life Cardiac Function and Heart Failure Risk: The ARIC StudySergio H R Ramalho, Brian L Claggett, George R Washko, et al.
Journal of the American College of Cardiology|July 16, 2016
Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure HospitalizationAkshay S Desai, Brian L Claggett, Milton Packer, et al.
The Lancet. Diabetes & Endocrinology|January 18, 2016
Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trialHiddo J L Heerspink, Frederik Persson, Barry M Brenner, et al.
Nature Communications|January 20, 2016
New observations on maternal age effect on germline de novo mutationsWendy S W Wong, Benjamin D Solomon, Dale L Bodian, et al.
Journal of the American Heart Association|November 23, 2014
Electrocardiographic deep terminal negativity of the P wave in V(1) and risk of sudden cardiac death: the Atherosclerosis Risk in Communities (ARIC) studyLarisa G Tereshchenko, Charles A Henrikson, Nona Sotoodehnia, et al.
Hypertension (Dallas, Tex. : 1979)|May 18, 2022
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities StudyJenifer M Brown, Magnus O Wijkman, Brian L Claggett, et al.
Journal of Cardiac Failure|May 31, 2022
Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCATEbrahim Barkoudah, Brian L Claggett, Eldrin F Lewis, et al.
Circulation|January 7, 2021
Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical TrialsRavi B Patel, Jozine M Ter Maaten, João Pedro Ferreira, et al.
Pageof 188